Veterinary Vaccines: Market Research Report

Date: January 2, 2014
Pages: 292
Price:
US$ 4,950.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: V21D0FDC69AEN
Leaflet:

Download PDF Leaflet

Veterinary Vaccines: Market Research Report
This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million by the following Product Segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines).

The report provides separate comprehensive analytics for the US, Europe, and Rest of World.

Annual estimates and forecasts are provided for the period 2013 through 2020.

Also, a seven-year historic analysis is provided for these markets.

Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs.

The report profiles 100 companies including many key and niche players such as -
  • Bayer HealthCare AG
  • Biogenesis-Bago
  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale
  • Heska Corporation
I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
A. Companion Animal Vaccines
B. Livestock Vaccines
Porcine Vaccines
Bovine Vaccines
Poultry Vaccines
Ovine Vaccines
Equine Vaccines
Other Animal Vaccines

II. EXECUTIVE SUMMARY

1.INDUSTRY OVERVIEW & OUTLOOK

Emergence of Newer Animal Diseases Drives the Global Veterinary Vaccines Market

Table 1. Global Animal Health Products Market by Product Group (2013): Percentage Share Breakdown by Value sales for Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives and Other Pharmaceuticals (includes corresponding Graph/Chart)
Table 2. Global Animal Health Products Market by Region (2013): Percentage Share Breakdown by Value Sales for North America, Europe, Latin America and Rest of World (includes corresponding Graph/Chart)

Market Outlook
Scientific R&D - Crucial for Market Growth
Mature Markets Vis-a-vis Emerging Markets
Market Challenges
A Highly Consolidated Market

2.MARKET TRENDS & ISSUES

Recombinant DNA Technology to Take Over the Industry
Improvised Adjuvant Usage and Veterinary Vaccine Delivery Systems
Global Efforts to Conquer FMD by an Effective Vaccine
Anthrax, Rabies, and Other Vaccines with Improved Adjuvants in the Pipeline
Pet Vaccines Trailing on a High Growth Track in Developing Countries
Over-Vaccination Trend May Prove Harmful
Egg-Derived Veterinary Vaccines in Human Vaccine Facilities
More Vaccines Needed to Prevent Zoonotic Infections
Developments in the Poultry Vaccine Market
Parasitic Vaccines Segment Holds Potential
Pricing Affects the Livestock Vaccine Market
OTC Market: A Potential Threat for Veterinarians
Vaccination – Critical for Controlling Avian Influenza Virus

3.PRODUCT OVERVIEW

Vaccines - An Evolutionary Scan
Veterinary Medicines - A Brief Review
Concept Development
Production of Vaccines
Veterinary Vaccines – An Essential Component of Animal Healthcare
What Does A Veterinary Vaccine Do?
Classification of Veterinary Vaccines
Companion Animal Vaccines
Canine Vaccines
Canine Distemper
Canine Parvovirus
Tracheobronchitis
Canine Coronavirus
Canine Leptospirosis
Canine Giardia
Canine Lyme borreliosis
Canine Rabies
Feline Vaccines
Feline Panleukopenia Virus Vaccine
Feline Calicivirus & Herpesvirus Vaccine
Rabies Virus Vaccine
Feline Leukemia Virus Vaccine
Chlamydia, Feline Infectious Peritonitis, and Ringworm Vaccines
Livestock Vaccines
Bovine Vaccines
Bovine virus diarrhoea - Mucosal disease (BVD-MD)
Johne's disease
Infectious Bovine Rhinotracheitis (IBR)
Blackleg
Neosporosis
Poultry Vaccines
Ovine Vaccines
Porcine Vaccines
Equine Vaccines
Aquaculture Vaccines
A Tabular Analysis on Select Animal Diseases Controlled by Vaccines
Vaccination and Its Reactions
Veterinary Vaccines- Latest Breakthroughs
Marker/DIVA Vaccines
DNA Vaccines
Gene-Deleted Vaccines
Viral-Vectored Vaccines

4.NOTES ON SELECT ANIMAL DISEASES

Brucellosis
Tuberculosis
Johne’s diseaseII-22Spirochete Associated Diseases
Respiratory Disease in Goats, Sheep, and Cattle
Porcine Respiratory Diseases
Mastitis
African swine fever
Avian Influenza
East Coast Fever
Hemorrhagic Septicemia
Foot-And-Mouth Disease
Japanese Encephalitis
Rift Valley Fever
Equine Virus Infection

5.PRODUCT LAUNCHES AND INNOVATIONS

Ceva Animal Health Vietnam Unveils Hyogen
Merck Introduces SE Guard Vaccine against Salmonella Enteritidis
Hygieia Biological Unveils New Vaccine for Streptococcus Mastitis
MSD Animal Health Announces Bovilis IBR Marker Inac
BIVI Launches New VETERA XP Vaccine Range
BIVI Launches FLEXcombo Vaccine
Merck Animal Health Launches Circumvent PCV G2 Vaccine
MSD Animal Health Introduces New Equilis Prequenza Vaccine
Zoetis Launches Bovi-Shield Gold One Shot Respiratory Vaccine
MSD Animal Health Introduces Nobivac L4 Vaccine
Merck Animal Health Unveils Vetsulin
Bayer Unveils Serersto Flea- and Tick- Collar for Cats and Dogs
MSD Animal Health Introduces INNOVAX-ND-SB in India
Zoetis Launches Fostera PCV MH Combination Vaccine
Boehringer Ingelheim Vetmedica Launches Vaccine for ERAV
Merck Animal Health Launches Bron-Newcavac-SETM
Pfizer Animal Health Introduces Poulvac E Coli
Ceva Sante Animale Launches Vectormune AI
Newport Laboratories Introduces ParaSail
Novartis Animal Health Launches BRD Shield
Ceva Animal Health Launches CEVAC CORYMUNE 7K and CEVAC CORYMUNE 4K
Pfizer Introduces Equivac HeV Vaccine
BIVI Unveils New Generation Canine Vaccine Line
Merial Animal Health Introduces New Pack Size of Circovac Vaccine
MSD Animal Health Unveils New Vaccine for Goats and Sheep
Virbac Launches First Vaccine in EU for Canine Leishmaniosis
Yissum Research and Development Announces Production of Vaccine to Offer Protection against CME
Virbac Introduces Bovidec
Intervet/Schering-Plough Animal Health Introduces a New Web Site for Innovax recombinant Vaccines Product Line
Pfizer Animal Health Introduces the First E. Coli Bacterial Extract Vaccine
Intervet/Schering-Plough Unveils BacuCheck ELISA Test
Merck Unveils Coccivac-D2 Poultry Vaccine
Merck Animal Health Introduces NOBIVAC Myxo-RHD Vaccine
Pfizer Animal Health Canada Introduces Fostera PCV Vaccine
Brentec Vaccines Introduces Poultry Vaccine
Intervet/Schering-Plough Animal Health Launches Atrophic Rhinitis Vaccine for Pigs
Merial Introduces VAXXITEK HVT + IBD Vaccine
Agrilabs Introduces MpB Cattle Vaccine
Ceva Launches New VECTORMUNE HVT-NDV Poultry Vaccine

6.RECENT INDUSTRY ACTIVITY

Elanco Inks Agreement to Take Over Assets of Lohmann SE and Lohmann Animal Health
Biogénesis Bagó to Construct FMD Vaccine Facility in China
Boehringer Ingelheim Teams Up with Taizhou China Medical City to Construct Veterinary Vaccines Production Plant
Heska Acquires 54.6% Majority Stake in Cuattro Veterinary USA
Harrisvaccines Expands Its License Agreement with Alphavax to Include Companion Animal Vaccines
AgriLabs Secures USDA Approval for Pulmo-Guard Vaccine for Cattle
IDT Acquires Assets of Riemser Pharma
MWI Veterinary Supply Acquires Assets of IVESCO Holdings
Imaxio Enters into R&D partnership agreement with VitamFero
Elanco Animal Health Signs Distribution Agreement for Prevtec’s Swine Vaccine
Valneva and Boehringer Ingelheim Ink Research License Agreement
Imaxio Inks Agreement with Leading Animal Health Laboratory
Heska Divests Assets to Elanco Animal Health
Bayer Expands its Centre for Innovation and Development
Bayer HealthCare Receives FDA Approval to Market ProstaMate and OvaCyst
MSD Presents Data Regarding Porcilis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Merck Animal Health’s Vista MLV Vaccine Line Gets USDA Approval
Harrisvaccines Expands License Agreement with AlphaVax
Virbac Gets Limited Marketing Authorization for Gudair
Merial Receives Exceptional Approval for Schmallenberg Vaccine in France
Zoetis China JV Receives Approval for Swine Vaccine
Vetanco Secures Approval from SENASA for BiotechVac Vaccine
Intercell Merges with Vivalis
Tianjin Ringpu Bio-technology Secures Approval from Ministry of Agriculture for Porcine Circovirus Type 2 Vaccine
Merial Korea Chusik Hoesa and Special Vaccine Ink Contract
Elanco Animal Health to Take Over Master Guard and Titanium Vaccine Brands of AgriLabs
Pfizer Animal Health Renames Escherichia coli Mastitis Vaccine to ENVIRACOR J-5
Global Green Awaits USDA Approval for Salmogenics Vaccine
Pfizer to Restructure Indian Animal Health Unit
Lohmann Animal Health Establishes Lohmann Animal Health Mexico
DSM and Merial Sign Collaboration Agreement for Producing Algae Based Vaccines
Heska Enters into Distribution Partnership with MWI Veterinary Supply
Bayer HealthCare Inks Agreement to Acquire KMG Chemicals' Animal Health Business
Pfizer’s Equivac HeV Vaccine for Equines Granted APVMA Approval
Boehringer Ingelheim to Expand Porcine Vaccines’ Production Capacity
BIVI Launches Bronchi-Shield ORAL
Sanofi Inks Agreement to Take Over Animal Health Division of Dosch Pharmaceuticals
Hester Biosciences and Innoves Animal Health Ink Business Transfer Agreement
Benchmark Holdings Acquires Braintree Vaccine Manufacturing Plant of Novartis Animal Health
Merial Takes Over Newport Laboratories
Delphi Announces Successful Application of Staby [R] Technology to DNA Vaccine In-Vivo Testing
FATRO and VIVALIS Ink Agreement
Kitasato Daiichi Sankyo Vaccine to Discontinue Animal Vaccine Business
Merial Unveils PUREVAX Recombinant FeLV
Merck Animal Health Develops Vaccine for Schmallenberg Virus
Antelope Valley Bios Secures Conditional License from United States Department of Agriculture
Pfizer Animal Health Expands its R&D Global Headquarters
Merck Renames Intervet/Schering-Plough Animal Health as Merck Animal Health
Sanofi and Merck to Operate Separate Animal Health Businesses
Centegen Inks Licensing Agreement with Merial for CEN-102 Staphylococcal Vaccine
Pfizer Poultry Health Acquires Alpharma
Virbac and Schweitzer Biotech to form Joint Venture SBC-Virbac
Pfizer Animal Health Enters into Agreement with Jilin Guoyuan Animal Health
Cadila Healthcare Acquires Bremer Pharma
IVRI Inks MoU with University of Glasgow and Moredun Research Institute
Vivalis and Kyoto Biken Laboratories Enter into Commercial Licensing Agreement
Xinjiang Tecon Animal Husbandry Biotechnology and Taiwan Maoxing Biotechnology Ink Licensing Agreement
The Ugandan Government Enters into Partnership with Brentec Vaccines International
Malaysian Government to Collaborate with Maryland University
Bioniche Life Sciences Sets up Vaccine Manufacturing Unit
Bayer Obtains European Commission’s Approval for Veraflox and Procox
MSD Expands Elkhorn Biotechnology Excellence Center’s Vaccination Unit
Hester Biosciences and Him Electronics Enter into Collaboration
Boehringer Ingelheim Secures Approval in Europe
Tangshan Yian Biological Engineering Secures Production License from Ministry of Agriculture for RabEnd
Merck Animal Health Secures Regulatory Approval to Commercialize AQUAVAC Strep Sa Vaccine in Brazil

7.FOCUS ON SELECT GLOBAL PLAYERS

Bayer HealthCare AG (Germany)
Biogenesis-Bago (Argentina)
Boehringer Ingelheim GmbH (Germany)
Ceva Santé Animale (France)
Heska Corporation (US)
Indian Immunologicals Ltd (India)
Lohmann Animal Health (US)
Merck Animal Health (US)
Merial Ltd. (US)
Protein Sciences Corporation (US)
Virbac SA (France)
Zoetis Inc. (US)

8.GLOBAL MARKET PERSPECTIVE

Table 3. World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 4. World Historic Review Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 5. World 15-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 6. World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 7. World Historic Review for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 8. World 15-Year Perspective for Companion Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 9. World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Product Segment - Canine Vaccines and Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 10. World Historic Review for Companion Animal Vaccines by Product Segment - Canine Vaccines and Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 11. World 15-Year Perspective for Companion Animal Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Canine Vaccines & Feline Vaccines Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 12. World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 13. World Historic Review for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 14. World 15-Year Perspective for Canine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 15. World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 16. World Historic Review for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 17. World 15-Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 18. World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 19. World Historic Review for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 20. World 15-Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 21. World Recent Past, Current & Future Analysis for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 22. World Historic Review for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 23. World 15-Year Perspective for Livestock Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 24. World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 25. World Historic Review for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 26. World 15-Year Perspective for Porcine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 27. World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region - US, Europe & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 28. World Historic Review for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 29. World 15-Year Perspective for Bovine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 30. World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 31. World Historic Review for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 32. World 15-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 33. World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 34. World Historic Review for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 35. World 15-Year Perspective for Ovine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 36. World Recent Past, Current & Future Analysis for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 37. World Historic Review for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 38. World 15-Year Perspective for Equine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 39. World Recent Past, Current & Future Analysis for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 40. World Historic Review for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 41. World 15-Year Perspective for Other Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


III. MARKET

1.THE UNITED STATES

A. Market Analysis
Food Safety Concerns and Biotechnological Offerings Drive the Vaccine Market
Dogs and Cats Obesity Vaccines Receive First US Patent
H5N1 Virus: A Conundrum for the US Industry
Product launches
Strategic Corporate Developments
Select Major Players
B. Market Analytics

Table 42. The US Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/ Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 43. The US Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 44. The US 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


2.EUROPE

A. Market Analysis
Steady Market Growth Expected Due to Superior Livestock Management
Regulations
EU Animal Welfare Strategy
Product Launches and Innovations
Strategic Corporate Developments
Select Major Players
B. Market Analytics

Table 45. European Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 46. European Historic Review for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 47. European 15-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 48. European Recent Past, Current & Future for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 49. European Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 50. European 15-Year Perspective for Veterinary Vaccines by Product Group/ Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


2A.FRANCE

A. Market Analysis
Product Launches and Innovations
Strategic Corporate Developments
Select Major Players
B. Market Analytics

Table 51. French Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 52. French Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 53. French 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


2B.GERMANY

A. Market Analysis
Strategic Corporate Developments
Select Major Players
B. Market Analytics

Table 54. German Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 55. German Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 56. German 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


2C.ITALY

A. Market Analysis
Strategic Corporate Development
B. Market Analytics

Table 57. Italian Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 58. Italian Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 59. Italian 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


2D.SPAIN

Market Analysis

Table 60. Spanish Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 61. Spanish Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 62. Spanish 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


2E.THE UNITED KINGDOM

A. Market Analysis
Product Launches and Innovations
Strategic Corporate Developments
B. Market Analytics

Table 63. The UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 64. The UK Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 65. The UK 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


2F.REST OF EUROPE

A. Market Analysis
A Review of Select Regional Markets
The Netherlands
Denmark
Russia Mass-Produces Vaccines against Avian Flu
B. Market Analytics

Table 66. Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 67. Rest of Europe Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 68. Rest of Europe 15-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


3.ASIA-PACIFIC

A. Market Analysis
Product Launches and Innovations
Strategic Corporate Developments
Select Key Player
Indian Immunologicals Ltd. (India)
B. Market Analytics

Table 69. Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 70. Asia-Pacific Historic Review for Veterinary Vaccines by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 71. Asia-Pacific 15-year Perspective for Veterinary Vaccines by Region - Percentage Breakdown of Dollar Sales for China and Rest of Asia-Pacific Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


3A.CHINA

A. Market Analysis
Increased Livestock Output and Emerging Pet Industry Lead to Higher Vaccine Demand
Growing Pet Industry Holds Promise
Threat of Avian Influenza Outbreaks Creates Market for Effective Vaccine
Demand for Higher-Quality Swine Fever Vaccine
Demand for Effective PRRS Vaccines by Foreign Manufacturers
FMD Epidemics Cause Increased demand for Vaccine
Effective Rabies Vaccine Needed to Curb Dog Menace
Highly Consolidated Chinese Veterinary Market
Product Launch
Strategic Corporate Developments
B. Market Analytics

Table 72. Chinese Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Segment - Porcine Vaccines, Poultry Vaccines, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 73. Chinese Historic Review for Veterinary Vaccines by Product Segment - Porcine Vaccines, Poultry Vaccines, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 74. Chinese 15-Year Perspective for Veterinary Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Poultry Vaccines, and Other Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


3B.REST OF ASIA-PACIFIC

A. Market Analysis
Focus on Select Regions
India
Major Players
Indigenous Bird Flu Vaccine by ICAR
North Korea
Taiwan
Taiwan’s Animal Healthcare Industry under Scan
Australia
A Note on Australian Veterinary Therapeutics Market
Vietnam
Vietnam Imports Bird Flu Vaccines
Product Launches and Innovations
Strategic Corporate Developments
Select Key Player
B. Market Analytics

Table 75. Rest of Asia-Pacific Recent Past, Current & Future Market Analysis for Veterinary Vaccines in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 76. Rest of Asia-Pacific Historic Review for Veterinary Vaccines in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)


4.LATIN AMERICA

A. Market Analysis
Strategic Corporate Developments
Biogenesis-Bagó – A Key Argentinian Player
B. Market Analytics

Table 77. Latin American Recent Past, Current & Future Analysis for Veterinary Vaccines by Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 78. Latin American Historic Review for Veterinary Vaccines by Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 79. Latin American 15-year Perspective for Veterinary Vaccines by Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


5.REST OF WORLD

A. Market Analysis
Focus on Select Regions
Canada
Overview of the Canadian Animal Health Industry
Imports and Manufacture of Veterinary Biologics
First to Access E. coli 0157:H7 Vaccine
Product Launches and Innovations
Strategic Corporate Development
B. Market Analytics

Table 80. Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 81. Rest of World Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 82. Rest of World 15-Year Perspective for Veterinary Vaccines by Product Group/ Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 100 (including Divisions/Subsidiaries - 123)
The United States (24)
Canada (2)
Japan (6)
Europe (36)
  France (4)
  Germany (8)
  The United Kingdom (5)
  Italy (3)
  Spain (4)
  Rest of Europe (12)
Asia-Pacific (Excluding Japan) (28)
Latin America (19)
Africa (5)
Middle East (3)
Vaccines - Armenia US$ 555.00 May, 2013 · 19 pages
Vaccines - Australia US$ 555.00 May, 2013 · 19 pages
Vaccines - Austria US$ 555.00 May, 2013 · 19 pages
Vaccines - Azerbaijan US$ 555.00 May, 2013 · 19 pages

Ask Your Question

Veterinary Vaccines: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: